Anne Mehlman Appointed as EVP and President of Crocs Brand Search Underway for New CFO
On February 1, 2024, a significant change took place within Crocs, Inc. Anne Mehlman, who had held the positions of...
Abeona Therapeutics Making Progress with Biologics License Application for Pzcel
Abeona Therapeutics has recently provided an update on the progress of the Biologics License Application (BLA) for their drug, Pz-cel....
SunCoke Energy Surpasses Earnings and Sales Expectations
On February 1, 2024, SunCoke Energy (NYSE:SXC) pleasantly surprised investors with their quarterly earnings report. They announced earnings of $0.16...
Purple Biotech Makes Groundbreaking Discovery in Cancer Treatment
Purple Biotech, a leading biotechnology company, has recently made a groundbreaking discovery in the field of cancer treatment. Their extensive...
Graviton Bioscience Secures Significant Investment from Sanofi for ROCK2 Inhibitor Treatments
On February 1, 2024, Graviton Bioscience, a cutting-edge biotechnology company, announced a significant investment from Sanofi, a leading pharmaceutical company....
Tractor Supplys Quarterly Earnings Report and Challenges
On February 1, 2024, Tractor Supply (NASDAQ:TSCO) surprised analysts with its quarterly earnings report, surpassing expectations with earnings of $2.28...
StoneCo NASDAQ STNE Downgraded to Neutral by UBS Analyst with Revised Price Target
On February 1, 2024, StoneCo (NASDAQ: STNE) experienced a significant shift in its stock rating as UBS analyst Kaio Prato...
Arrow Financial Corporation Experiences Decline in Q4 GAAP EPS and Cash Reserves
As of February 1, 2024, Arrow Financial Corporation delivered a notable decline in its Q4 GAAP EPS, plummeting from $0.71...
Analyst Ratings and Price Targets for Helmerich Payne HP Stock
As of January 31, 2024, there have been several analyst ratings for Helmerich & Payne (HP) stock, showcasing a diverse...
Analysts Maintain Hold Rating with Moderate Upside for Goosehead Insurance
On January 31, 2024, Truist Securities analyst Mark Hughes decided to maintain a Hold rating on Goosehead Insurance (NASDAQ: GSHD)...
Don't Miss It
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows
